Prostate cancer op had ‘Elvis’ back rockin’ in next to no time
Elvis impersonator Alan Moore was back on stage perfomring just three days after undergoing brachytherapy to treat his prostate cancer (reports The Daily Mail Scottish Edition).
Brachytherapy and the treatment of prostate cancer
Prostate cancer is the most commonly diagnosed cancer in men. One in eight men in the UK will be diagnosed with the disease during their lifetime*. Despite this, the choice of treatment methods and their availability which is often dependent on where you live, means that for many patients who are diagnosed with the disease, understanding and receiving the best treatment can be a lottery.
Now, new research has revealed that a non-surgical, minimally evasive treatment option - known as seed or LDR brachytherapy - offers the best chance for long term survival for prostate cancer patients. In addition it is proved to be one of the least expensive treatment options available, offering significant cost savings to the NHS.**
An international study, undertaken by Prostate Cancer Treatment Research Centre (PCRSG) which compares prostate cancer outcomes and measures the long term survival rates from different prostate cancer treatments, has concluded that seed or LDR brachytherapy is the most effective treatment for long-term survival.
With over 47,000 men diagnosed with prostate cancer in the UK during 2013, these findings could have a significant impact on the type of treatment that men diagnosed with prostate cancer choose to undertake.